🦠 CONGENITAL CMV — ZERO-OMISSION MASTER TABLES

TABLE 1 — MICROBIOLOGY & VIROLOGY

TABLE 2 — TRANSMISSION (INCLUDING PREGNANCY RELEVANCE)

TABLE 3 — PRIMARY VS REACTIVATION (EXAM DIFFERENTIATOR)

TABLE 4 — WHY CMV IS DANGEROUS IN PREGNANCY

TABLE 5 — FETAL TRANSMISSION RISK

TABLE 6 — CONGENITAL CMV: FETAL EFFECTS (CORE EXAM TABLE)

A. CNS (MOST TESTED)

B. GROWTH & SYSTEMIC

TABLE 7 — DIAGNOSIS IN PREGNANCY (MOTHER)

TABLE 8 — FETAL DIAGNOSIS

TABLE 9 — MANAGEMENT IN PREGNANCY (HIGH-YIELD)

TABLE 10 — PRIMARY MATERNAL CMV: STEPWISE MANAGEMENT

TABLE 11 — FETAL MONITORING

TABLE 12 — SEVERE FETAL DISEASE: DECISION MAKING

TABLE 13 — NEONATAL MANAGEMENT

TABLE 14 — POSTNATAL (BREAST MILK) CMV — EXAM TRAP

TABLE 15 — ULTRA-HIGH-YIELD EXAM SUMMARY (ONE-LOOK TABLE)

PART 1 — MICROBIOLOGY

1. Virus Basics

• Herpesviridae family (HHV-5)
• Enveloped, double-stranded DNA virus
• Latent for life → reactivation
• Infects salivary glands, kidneys, leukocytes

💡 Memory hook:

“Herpes hides; CMV hides in many places.”

2. Characteristic Findings

• Causes cytomegaly → large cells with “owl’s-eye” intranuclear inclusions
• CMV = largest human herpesvirus

3. Transmission

• Saliva
• Urine
• Sexual contact
• Blood transfusion
• Breast milk
• Transplacental (MOST important in pregnancy)
• Organ transplant

💡 Memory hook:

“Everything wet spreads CMV.”

4. Primary vs Reactivation

• Primary infection = highest fetal risk
• Reactivation in immune mother = fetal disease rare

5. Why dangerous in pregnancy?

• CMV is the most common congenital infection worldwide
• Often asymptomatic in mother → silent fetal damage

💡 Memory hook:

“Mother fine → baby not fine.”

PART 2 — FETAL EFFECTS (THE MAIN EXAM TARGET)

⭐ Primary maternal CMV → fetal transmission risk

• 30–40% risk of transmission
• Worse if infection 1st or 2nd trimester

⭐ Congenital CMV Features

(These MUST be in your answer)

1. CNS

• Microcephaly
• Periventricular calcifications (classic)
• Seizures
• Developmental delay
• Sensorineural hearing loss (most common long-term effect)

💡 Memory hook: “Brain shrinks + calcifies + deafness.”

2. Growth + Systemic

• IUGR
• Hepatosplenomegaly
• Jaundice
• Thrombocytopenia → “blueberry muffin” rash
• Ascites

💡 Memory hook: “IUGR + liver + low platelets.”

PART 3 — DIAGNOSIS IN PREGNANCY

Maternal

• CMV IgM = suggests recent infection (but false positives!)
• Rising IgG titres = primary infection
• IgG avidity
• Low avidity = recent infection
• High avidity = past infection

⭐ Exam trick:

IgM alone NEVER diagnoses primary CMV infection.

Fetal

• Amniocentesis after 21 weeks and ≥6–7 weeks after maternal infection
• Test amniotic fluid PCR for CMV DNA
• Targeted fetal ultrasound for:
• Ventriculomegaly
• Microcephaly
• Ascites
• Echogenic bowel
• Hepatosplenomegaly

PART 4 — MANAGEMENT OF CMV IN PREGNANT MOTHERS

⭐ There is NO vaccine and NO routine antiviral treatment for the mother.

(VERY high-yield exam point)

A. If mother has PRIMARY CMV infection

1. Counsel on fetal risks

• Transmission ~40%
• Severe outcomes mainly if in 1st trimester

2. High-dose Valaciclovir (newer evidence)

• Dose: 8 g/day (2 g QID)
• Reduces fetal CMV risk/severity
• Used in many centers but not universal guideline
• Safe in pregnancy

💡 Remember:

Not curative; risk-reduction only.

3. Fetal monitoring

• Serial ultrasound (q2–4 weeks)
• Middle cerebral artery Doppler (for anemia)
• Growth scans
• Neurosonography

4. Fetal diagnosis

• Amniocentesis ≥21 weeks → CMV PCR
• If positive → detailed counselling

B. If severe fetal disease is detected

• Microcephaly, ventriculomegaly, hydrops, severe growth restriction

→ Consider termination depending on gestation and local laws.

PART 5 — NEONATAL MANAGEMENT

If congenital CMV confirmed

• IV Ganciclovir or Valganciclovir for 6 months
• Improves hearing & neurodevelopment
• Monitor for neutropenia

If only perinatal CMV (from breastmilk)

• Usually mild → no specific antiviral therapy needed

PART 6 — THE ULTRA-HIGH-YIELD SUMMARY (read this twice)

🔥 Microbiology

• dsDNA, enveloped, Herpesvirus-5
• Owl’s-eye inclusions
• Latent lifelong
• Transmitted by any bodily fluid
• Most common congenital infection

🔥 Fetal effects

• Microcephaly
• Periventricular calcifications
• Sensorineural deafness
• IUGR
• Hepatosplenomegaly
• Blueberry muffin rash

🔥 Diagnosis

• Mother: IgG avidity + IgM
• Fetus: Amniotic fluid PCR (after 21 weeks)

🔥 Management

• No vaccine
• No routine antivirals for mother
• High-dose valaciclovir may reduce transmission
• Fetal monitoring with serial ultrasound
• Neonate: ganciclovir/valganciclovir if symptomatic

ELABORATIVE CLINICAL SCENARIO — CONGENITAL CMV (ZERO-OMISSION, EXAM-READY)

👩‍🍼 The Mother (Silent Beginning)

A 26-year-old primigravida, schoolteacher, presents at 11 weeks’ gestation for routine booking.

She feels entirely well—no fever, no rash, no lymphadenopathy. She casually mentions frequent contact with young children at work and at home.

Key silent danger: CMV in pregnancy is often asymptomatic in the mother.

Routine antenatal screening is unremarkable. No TORCH testing is done initially (as per standard practice).

🧪 The Trigger (Subtle Serology Clue)

At 14 weeks, she requests reassurance after a colleague’s child is diagnosed with CMV.

Maternal serology shows:

• CMV IgM: positive
• CMV IgG: positive

⚠️ Critical exam rule applied immediately:

IgM ALONE NEVER diagnoses primary CMV infection.

So the obstetrician orders IgG avidity testing.

• Result: LOW IgG avidity

👉 Interpretation:

This confirms a RECENT PRIMARY CMV INFECTION, acquired in early pregnancy (1st trimester) — the highest-risk period for fetal damage.

🧠 Counselling Moment (High-Stakes Discussion)

She is counselled that:

• Fetal transmission risk ≈ 30–40%
• Risk is highest in 1st and 2nd trimesters
• Even if infected, severity varies
• Mother may remain completely asymptomatic
• Fetal damage can be severe and permanent

Memory lock:

“Mother fine → baby not fine.”

💊 Risk-Reduction Strategy (Not Curative)

Because this is confirmed primary infection, she is offered:

• High-dose Valaciclovir
• 8 g/day (2 g QID)
• Explained clearly:
• No cure
• May reduce fetal transmission and severity
• Not yet universal guideline, but supported by growing evidence
• Considered safe in pregnancy

She agrees and treatment is started.

👶 Fetal Surveillance Phase (Weeks Matter)

Serial monitoring begins:

Ultrasound at 20–22 weeks shows:

• Mild ventriculomegaly
• Echogenic foci around ventricles
• Fetal growth lagging (early IUGR)

These findings immediately raise suspicion for congenital CMV CNS involvement.

🧬 Definitive Fetal Diagnosis

At 22 weeks (≥21 weeks and >6–7 weeks after maternal infection):

• Amniocentesis performed
• Amniotic fluid CMV PCR: POSITIVE

👉 This confirms fetal infection.

🧠 Progressive Fetal Findings (The Classic Pattern Unfolds)

Over the next weeks, targeted neurosonography and growth scans reveal:

CNS

• Progressive microcephaly
• Periventricular calcifications (classic)
• Increasing ventriculomegaly

Systemic

• Severe IUGR
• Hepatosplenomegaly
• Ascites
• Evidence of thrombocytopenia

Exam-critical triad memory hook:

“Brain shrinks + calcifies + deafness.”

⚖️ Decision Point (Severe Disease)

With:

• Proven fetal CMV infection
• Structural brain damage
• Severe growth restriction
• Poor neurodevelopmental prognosis

She receives multidisciplinary counselling (OB + neonatology + fetal medicine).

Depending on gestational age and local legal framework, termination of pregnancy is discussed as a medically justified option.

🧑‍🍼 ALTERNATIVE ENDING — If Pregnancy Continues

The baby is delivered at 36 weeks due to growth restriction.

👶 Neonatal Findings

• Low birth weight
• Microcephaly
• Hepatosplenomegaly
• Petechiae → “blueberry muffin” rash
• Failed newborn hearing screen

Diagnosis confirmed by:

• Neonatal CMV PCR (urine/saliva)

💉 Neonatal Management

Because the infant is symptomatic congenital CMV:

• IV Ganciclovir → oral Valganciclovir
• Total duration: 6 months
• Purpose:
• Improve hearing outcomes
• Improve neurodevelopment
• Close monitoring for:
• Neutropenia
• Liver function

🍼 Important Contrast (Exam Trap)

If the baby had acquired CMV postnatally from breast milk:

• Usually mild or asymptomatic
• NO antiviral treatment required

🔥 FINAL CLINICAL INTEGRATION (WHAT THE EXAMINER EXPECTS)

• CMV = most common congenital infection worldwide
• Primary maternal infection is the dangerous one
• IgG avidity is the key diagnostic discriminator
• Amniotic fluid PCR after 21 weeks = fetal diagnosis
• CNS damage + IUGR + thrombocytopenia = classic
• No vaccine
• No routine maternal antivirals
• Valaciclovir = risk reduction, not cure
• Neonatal ganciclovir/valganciclovir ONLY if symptomatic